Home/Filings/4/0001178913-26-000017
4//SEC Filing

Malca Yonatan 4

Accession 0001178913-26-000017

CIK 0001638097other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:23 PM ET

Size

7.5 KB

Accession

0001178913-26-000017

Insider Transaction Report

Form 4
Period: 2026-01-01
Transactions
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2026-01-01+30,15777,416 total
  • Award

    Stock Option (right to buy)

    2026-01-01+33,50533,505 total
    Exercise: $1.94Exp: 2036-01-01Ordinary Shares, par value NIS 0.0000769 per share (33,505 underlying)
Footnotes (2)
  • [F1]The Board of Directors ("Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the 2025 fiscal year.
  • [F2]These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2026.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904759

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:23 PM ET
Size
7.5 KB